Synthesis and Preclinical Evaluation of a Highly Improved Anticancer Prodrug Activated by Histone Deacetylases and Cathepsin L

DOI: 10.7150/thno.13826

Keywords: targeted therapy, prodrug, histone deacetylase, cathepsin L, drug development.

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text